Literature DB >> 15213123

In vivo interleukin-6 protects neutrophils from apoptosis in osteomyelitis.

Víctor Asensi1, Eulalia Valle, Alvaro Meana, Joshua Fierer, Antonio Celada, Victoria Alvarez, José Paz, Eliecer Coto, José Antonio Carton, José Antonio Maradona, Angeles Dieguez, Julián Sarasúa, Marcos G Ocaña, José Manuel Arribas.   

Abstract

Polymorphonuclear neutrophils are critical for resolution of bacterial infections. In tissues, most of the neutrophils quickly die through apoptosis. Using propidium iodide DNA staining and DNA gel electrophoresis, we found that spontaneous apoptosis of neutrophils from patients suffering osteomyelitis (n = 52) was significantly decreased in relation to control neutrophils (n = 20) (40.2% +/- 25.2% versus 54.5% +/- 23.5%; P < 0.03). Incubation of neutrophils from normal volunteers with sera from patients with osteomyelitis reduced apoptosis from 79.1% +/- 14.8% in control sera to 62.2% +/- 18.7% in osteomyelitis sera. A significant increase of serum interleukin-6 (IL-6) and IL-1alpha was found in osteomyelitis (IL-6, 8.8 +/- 11.9 pg/ml versus 1.8 +/- 1.2 pg/ml in controls [P < 0.004]; IL-1alpha, 3.8 +/- 6.4 pg/ml versus 1.0 +/- 2.2 pg/ml in controls [P < 0.02]). No differences in the levels of other cytokines, such as tumor necrosis factor alpha, were found. There was an inverse correlation between IL-6 levels and neutrophil apoptosis (r = -0.855; P < 0.007), but this was not the case for other cytokines. The antiapoptotic effect of the osteomyelitis sera was reversed with anti-IL-6 antibodies (P < 0.03) and was reproduced with recombinant human IL-6 (P < 0.001). The longer life span of neutrophils in osteomyelitis induced by IL-6 could contribute to the tissue damage that occurs in these chronic bone infections.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15213123      PMCID: PMC427428          DOI: 10.1128/IAI.72.7.3823-3828.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

Review 1.  The acute phase response.

Authors:  H Baumann; J Gauldie
Journal:  Immunol Today       Date:  1994-02

2.  Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils.

Authors:  K Iwai; T Miyawaki; T Takizawa; A Konno; K Ohta; A Yachie; H Seki; N Taniguchi
Journal:  Blood       Date:  1994-08-15       Impact factor: 22.113

Review 3.  Regulation of apoptosis in neutrophils--Fas track to death?

Authors:  W C Liles; S J Klebanoff
Journal:  J Immunol       Date:  1995-10-01       Impact factor: 5.422

4.  Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators.

Authors:  A Lee; M K Whyte; C Haslett
Journal:  J Leukoc Biol       Date:  1993-10       Impact factor: 4.962

5.  Rapid acceleration of neutrophil apoptosis by tumor necrosis factor-alpha.

Authors:  Y Takeda; H Watanabe; S Yonehara; T Yamashita; S Saito; F Sendo
Journal:  Int Immunol       Date:  1993-06       Impact factor: 4.823

6.  Staphylococcus aureus infection of mouse or human osteoblasts induces high levels of interleukin-6 and interleukin-12 production.

Authors:  K L Bost; W K Ramp; N C Nicholson; J L Bento; I Marriott; M C Hudson
Journal:  J Infect Dis       Date:  1999-12       Impact factor: 5.226

7.  Interleukin-6 suppression of neutrophil apoptosis is neutrophil concentration dependent.

Authors:  W L Biffl; E E Moore; F A Moore; C C Barnett
Journal:  J Leukoc Biol       Date:  1995-11       Impact factor: 4.962

8.  IL-1 alpha (-889) promoter polymorphism is a risk factor for osteomyelitis.

Authors:  Víctor Asensi; Victoria Alvarez; Eulalia Valle; Alvaro Meana; Joshua Fierer; Eliecer Coto; José Antonio Carton; José Antonio Maradona; José Paz; Maria Angeles Dieguez; Belén de la Fuente; Alfonso Moreno; Silvino Rubio; Maria José Tuya; Julián Sarasúa; Sara Llames; José Manuel Arribas
Journal:  Am J Med Genet A       Date:  2003-06-01       Impact factor: 2.802

9.  Impaired immune and acute-phase responses in interleukin-6-deficient mice.

Authors:  M Kopf; H Baumann; G Freer; M Freudenberg; M Lamers; T Kishimoto; R Zinkernagel; H Bluethmann; G Köhler
Journal:  Nature       Date:  1994-03-24       Impact factor: 49.962

10.  A possible role of sphingosine in induction of apoptosis by tumor necrosis factor-alpha in human neutrophils.

Authors:  H Ohta; Y Yatomi; E A Sweeney; S Hakomori; Y Igarashi
Journal:  FEBS Lett       Date:  1994-12-05       Impact factor: 4.124

View more
  33 in total

1.  On-chip evaluation of neutrophil activation and neutrophil-endothelial cell interaction during neutrophil chemotaxis.

Authors:  Donghyuk Kim; Christy L Haynes
Journal:  Anal Chem       Date:  2013-10-28       Impact factor: 6.986

2.  Disentangling the effects of tocilizumab on neutrophil survival and function.

Authors:  Timo Gaber; Martin Hahne; Cindy Strehl; Paula Hoff; Yvonne Dörffel; Eugen Feist; Gerd-Rüdiger Burmester; Frank Buttgereit
Journal:  Immunol Res       Date:  2016-06       Impact factor: 2.829

3.  Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model.

Authors:  Jadwiga Jablonska; Sara Leschner; Kathrin Westphal; Stefan Lienenklaus; Siegfried Weiss
Journal:  J Clin Invest       Date:  2010-03-08       Impact factor: 14.808

4.  Contribution of Reduced Interleukin-10 Levels to the Pathogenesis of Osteomyelitis in Children with Sickle Cell Disease.

Authors:  Sameh Sarray; Wassim Y Almawi
Journal:  Clin Vaccine Immunol       Date:  2015-07-01

5.  Murine osteoblasts respond to LPS and IFN-gamma similarly to macrophages.

Authors:  Kenta Maruyama; Gen-Ichiro Sano; Koichi Matsuo
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

6.  Hodgkin's lymphoma masquerading as vertebral osteomyelitis in a man with diabetes: a case report.

Authors:  Rachel A Bender Ignacio; Anne Y Liu; Aliyah R Sohani; Jatin M Vyas
Journal:  J Med Case Rep       Date:  2010-04-06

7.  Neutrophils rescue gingival epithelial cells from bacterial-induced apoptosis.

Authors:  Johnah C Galicia; Manjunatha R Benakanakere; Panagiota G Stathopoulou; Denis F Kinane
Journal:  J Leukoc Biol       Date:  2009-04-23       Impact factor: 4.962

8.  The Toll-like receptor 4 (Asp299Gly) polymorphism is a risk factor for Gram-negative and haematogenous osteomyelitis.

Authors:  A H Montes; Victor Asensi; Victoria Alvarez; Eulalia Valle; M G Ocaña; A Meana; J A Carton; Jose Paz; J Fierer; A Celada
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

Review 9.  Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor.

Authors:  Jean-Michel Dayer; Ernest Choy
Journal:  Rheumatology (Oxford)       Date:  2009-10-23       Impact factor: 7.580

10.  Smoking, an additional risk factor in elder women with primary open-angle glaucoma.

Authors:  Vicente Zanon-Moreno; Jose J Garcia-Medina; Vicente Zanon-Viguer; Maria A Moreno-Nadal; Maria D Pinazo-Duran
Journal:  Mol Vis       Date:  2009-12-31       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.